Which brace cuff is best? small study tests comfort and performance
NCT ID NCT05456295
First seen Jun 27, 2026 ยท Last updated Jun 27, 2026
Summary
This study tested four different cuff designs for carbon fiber ankle-foot orthoses (braces) in 35 healthy adults and people with ankle arthritis or injury. Researchers measured comfort, pain, foot pressure, and walking mechanics to see which cuff design people liked best. The goal is to improve brace design for better fit and function.
What this could mean
Our plain-language read of the trial. This is informational only โ not medical advice or a prediction.
- Active substance
- Carbon fiber custom dynamic orthosis (ankle-foot orthosis) with different cuff designs
- What this could lead to
- If successful, this could help design more comfortable and effective braces for people with ankle injuries or arthritis.
- What could go wrong
- This is a small, completed study with only 35 participants, so results may not apply to everyone. It focuses on short-term comfort and mechanics, not long-term outcomes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Iowa
Iowa City, Iowa, 52241, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a new oral drug change future treatments? early safety trial begins
- Can brain scans unlock the secret to hearing in crowded rooms?
- Can a Light-Guided device make arterial sticks easier?
- Water workouts could be the key to back pain relief
- Could everyday disinfectants be harming us? a new study investigates
- Can a new drug keep the Heart's beat steady? trial puts verducatib to the test